Diabetic Nephropathy Treatment
Diabetic Nephropathy Treatment
Treating diabetic kidney disease is mostly not dramatic. It is a foundation of four layers — glucose, blood pressure with a medicine that lowers pressure inside the filter itself, an SGLT2 inhibitor, and, where filtration has already fallen, an anti-fibrotic agent — taken consistently for years. What changes the outcome is not any single medicine but the combination, and the order in which it is built. This page sets out each layer, what happens in advanced disease, and how the plan is held together.
Glucose — and why the target moves
Glucose is where every patient expects the treatment to be, and it is one leg rather than both. Bringing the long-term glucose average down reduces the chance of albumin appearing and slows its progression once it has. It does not, on its own, address the pressure inside the filtering unit, which is the other half of what is happening.
The target is not a fixed number, and the direction in which it moves surprises people. Early in kidney disease, a tighter target is reasonable and is where most of the long-term benefit lies. Once filtration has fallen substantially, it is deliberately relaxed — for two reasons that have nothing to do with being less ambitious.
| Change | What it means in practice |
|---|---|
| Medicines cleared by the kidney last longer | Insulin and several oral agents accumulate, so the same dose produces a lower glucose for longer and hypoglycaemia becomes a real hazard |
| The kidney stops contributing to glucose handling | Both the production and the clearance of glucose change, making levels less predictable from dose to dose |
| The long-term average becomes less reliable | Red cell survival changes at reduced filtration, so the number can read lower or higher than the true exposure |
| Appetite and nutrition become variable | Nausea and reduced intake make a tight target unsafe rather than merely difficult |
| Hypoglycaemia carries more consequence | A severe low becomes more dangerous than the modest hyperglycaemia it was treating |
In practice this means the medicines are revised before the target is: agents that depend on kidney clearance are stopped or reduced, doses are reviewed at each stage change, and continuous or home monitoring carries more weight than the periodic average. Glucose management is run together with the endocrine team; the kidney side of the plan is what this cluster follows.
Blood pressure, and the medicines that lower pressure inside the filter
Blood pressure is the half of the treatment that patients underestimate, because it has no symptoms either. Pressure transmitted into the filtering unit is what drives protein through a loosening barrier and what converts inflammation into scar. Controlling it is not a cardiovascular afterthought in this disease — it is the treatment.
The medicines of choice are an ACE inhibitor or an angiotensin receptor blocker, and they are preferred for a reason beyond their effect on the reading. Both dilate the vessel leaving the filter more than the vessel entering it, which lowers the pressure inside the filtering unit itself rather than only in the arm. Protein loss falls as a consequence, and it falls more than it would with another agent producing the same blood pressure.
| Element | What it contributes |
|---|---|
| An ACE inhibitor or angiotensin receptor blocker, to the maximum tolerated dose | Lower pressure inside the filtering unit, and a fall in albumin loss that is independent of the blood pressure reading |
| Sodium restriction | Does more for the pressure — and for the proteinuria — than most people expect, and makes every medicine above work better |
| A diuretic where fluid is being retained | Removes the salt and water that make the pressure resistant to everything else |
| Home or ambulatory measurement | Finds the uncontrolled night-time and early-morning pressure that a clinic reading misses |
| A review of everything else being taken | Decongestants, anti-inflammatory medicines and some supplements work directly against the above |
None of these is reached in a single visit. Building the regimen, checking potassium and creatinine afterwards and adjusting takes months, and that period is the treatment rather than a delay before it. The targets being aimed at, and how often they are measured, are set out on the prevention page.
The medicines that slow the loss of filtration
Two classes have changed what is achievable in this disease, and they are now part of the foundation rather than reserved for later. Both are started alongside the measures above rather than after them, and neither replaces any of them.
| Medicine | What it does | What is monitored |
|---|---|---|
| SGLT2 inhibitor | Reduces pressure inside the filtering unit and slows the loss of filtration over years; also protects against heart failure irrespective of the glucose effect | An initial dip in filtration that is expected and not a reason to stop; hydration; genital infection |
| Finerenone | A non-steroidal mineralocorticoid receptor antagonist that reduces albuminuria and cardiovascular events where filtration is already reduced | Potassium, checked after starting and after any dose change; filtration |
| GLP-1 receptor agonist | Addresses glucose, weight and cardiovascular risk together, with kidney outcomes studied alongside them | Gastrointestinal tolerance; the rest of the glucose regimen, which may need reducing |
| Statin and antiplatelet therapy where indicated | Cardiovascular risk, which in this disease is the larger threat to life expectancy | Liver enzymes; muscle symptoms |
Two cautions. Availability and approved indications differ between countries, so what is prescribed here may be familiar under a different name or may not be available where you live — and that is a conversation to have with your own clinician rather than an assumption. And these medicines do not make the foundation optional: a person taking an SGLT2 inhibitor while eating a high-sodium diet, smoking and taking an anti-inflammatory daily has added a medicine to a problem rather than treating it.
Advanced disease, and planning years ahead
Where filtration falls far enough, the aim changes rather than ending. The work shifts from slowing loss to planning its replacement, and the value of that planning lies almost entirely in when it happens.
| Element | Why it is done early |
|---|---|
| Vascular access for haemodialysis | A fistula needs weeks to mature before it can be used; formed late, it forces a temporary catheter instead |
| Peritoneal dialysis catheter placement and training | Requires a healing period and a taught technique before it can be relied on at home |
| Transplantation assessment | A workup and a possible living donor assessment take months; starting late means starting on dialysis instead |
| Anaemia, bone and acid–base management | These are treated while filtration is falling, not after it has gone |
| Medicine review at each stage change | Doses and choices that were correct six months ago may be harmful now |
| A written plan with dates | Makes the transition a scheduled event rather than an emergency admission |
Our nephrology department provides haemodialysis, peritoneal dialysis with catheter placement, vascular access establishment and maintenance, and transplantation assessment within the same service that runs the outpatient and inpatient kidney programme — and the planning above is what that continuity exists for. What happens after a first assessment, and what it costs, is set out on the practical questions page.
Where traditional Chinese medicine fits
The traditional Chinese medicine department runs a dedicated kidney disease clinic, and a substantial number of patients in our kidney programme use it alongside their prescribed treatment. The position we take is specific, and it is the same one we would want stated to us.
It is an addition, not a substitute. A herbal regimen does not bring blood pressure to target on its own, does not replace an ACE inhibitor, an SGLT2 inhibitor or any glucose-lowering medicine, and does not make monitoring unnecessary. Where patients describe benefit, it is most often in areas the prescription medicines do not reach well — appetite, sleep, energy and the sensation of cold or heat — and those are worth treating.
Two conditions decide whether a combined pathway is safe. The first is that the prescription is visible to the nephrologist: some herbal preparations contain compounds that matter to the kidney, and some interact with prescribed medicines, and neither can be checked if nobody knows what is being taken. The second is that the measurements continue at the same intervals — albumin, filtration, potassium and blood pressure — so that an effect, good or bad, is visible rather than assumed.
Living with the plan
What patients do between appointments matters more than what happens in them, and most of it is a short list of things to protect rather than a long list of things to add.
| Question | The answer |
|---|---|
| Can I take ibuprofen for joint pain? | Not regularly. Anti-inflammatory medicines reduce blood flow to the kidney and are a common cause of a sudden step down in filtration; occasional use is a conversation, regular use is not |
| Does a scan with contrast put the kidney at risk? | It can. Mention the diagnosis before any scan so that hydration and alternatives are arranged beforehand rather than discussed afterwards |
| How much fluid should I drink? | Enough to avoid thirst and to keep urine pale; deliberate large volumes do not protect the kidney, and dehydration during illness is a real hazard |
| Should I change my protein intake? | Very high intake is worth moderating once filtration has fallen. A restrictive special diet is not needed earlier and should not be undertaken unsupervised |
| Do I need to worry about hypoglycaemia? | Increasingly, as filtration falls. Know the symptoms, carry glucose, and ask for the regimen to be reviewed after any change in filtration |
| What about exercise, smoking and vaccination? | Regular exercise and stopping smoking are among the most effective things available; keep vaccinations current, since infection is a common precipitant of a step down |
What matters more than any of it is a record. Albumin, filtration, potassium and blood pressure with dates, in one place. A trend written down is the most useful thing a patient can bring to any appointment — including the remote review described on the practical questions page.